« Back to Record
Limentani, S. S., Disis, M., Awada, A., Berlière, M., Amant, F., Levine, E., Burny, W., Callegaro, A., De Sousa Alves, P. M., Louahed, J., Brichard, V., Csampone, M., Lehmann, F., Dorval, T., Curigliano, G., de Boer, R., Vogel, C., White, S., Bachelot, T., & Canon, J.-L. (2016). A non-randomized dose-escalation phase i trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors. Breast cancer research and treatment, 156(2), 319-330. doi:10.1007/s10549-016-3751-x
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247839



